Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction [0.03%]
心肌梗死后急性心力衰竭患者血钾水平短期死亡风险
Maria Lukács Krogager,Lotti Eggers-Kaas,Kristian Aasbjerg et al.
Maria Lukács Krogager et al.
Aims: Diuretic treatment is often needed in acute heart failure following myocardial infarction (MI) and carries a risk of abnormal potassium levels. We examined the relation between different levels of potassium and mort...
Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions [0.03%]
塞地替德：一种新型双效颗粒鸟苷酸环化酶受体激动剂的结构要求，具有体内和体外肾增强作用
Candace Y W Lee,Brenda K Huntley,Daniel J McCormick et al.
Candace Y W Lee et al.
Aims: Cenderitide is a novel dual natriuretic peptide (NP) receptor chimeric peptide activator, which targets the particulate guanylyl cyclase B (pGC-B) receptor and pGC-A unlike native NPs. Cenderitide was engineered to ...
Impact of a personalized, strike early and strong lipid-lowering approach on LDL-cholesterol levels and cardiovascular outcome in patients with acute myocardial infarction [0.03%]
早期高强度他汀个性化强化降脂治疗对急性心肌梗死患者低密度脂蛋白胆固醇水平及心血管转归的影响：设计与方法学概述
Aims: Considering the lack of evidence, we evaluated the impact on cardiovascular outcome of the systematic introduction in our institution of a personalized strike early and strong (SES) approach for lipid-lowering thera...